Recently, interest surrounding GHK-Cu or copper peptides has steadily grown
In late 2023, the FDA moved several commonly used peptides to Category 2 of its bulk drug substance list
TABLE 3 Pharmacokinetic parameters of BPC157 in rats following repeat intramuscular administration of 100 g/kg BPC157 for seven consecutive days (mean SD, n = 6)
For skin and hair goals, physician-prescribed compounded topical GHK-Cu from a licensed 503A compounding pharmacy is the best option, because it delivers therapeutic concentrations directly to the target tissue with physician oversight and pharmaceutical-grade quality assurance
Meniscus tears in the avascular zone remain among the hardest knee injuries to treat with any intervention
According to Reuters reporting on the vote, the panel recommended placing BPC-157 on the list that governs pharmacy compounding